Your session is about to expire
← Back to Search
Treatment for Inflammatory Bowel Disease
Study Summary
This trial is testing whether dietary ganglioside is an effective treatment for pediatric patients with inflammatory bowel disease. The primary outcome is the disease activity index, and secondary outcomes include quality of life, intestinal permeability, and C-reactive protein levels.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have a history of drug or alcohol abuse.You have other significant health issues.Your disease is located in the small intestine, colon or both.You are pregnant.You have had surgery to remove a part of your bowel in the past.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many individuals are taking part in this clinical research project?
"Affirmative. Clinicaltrials.gov has proof that this clinical trial is actively seeking participants, with 48 openings at one location since it was initially posted on June 28th 2021 and last edited on July 25th 2022."
Does this clinical trial accommodate individuals aged eighty and over?
"The qualifications for this medical trial mandate that participants are between 9 and 21 years old."
Who is considered to be the most suitable candidates for this experimental program?
"This clinical trial is looking for 48 subjects, aged between 9 and 21 years old, currently diagnosed with Inflammatory Bowel Disease. Eligible participants must meet the following requirements: age within 9-21 range; mild to moderate IBD according to ImproveCareNow Physician Global Assessment (PGA); or stable severe IBD according to ICN PGA in case it has been present for at least 120 days; ileal, ileocolonic or colonic location of disease."
Is this clinical trial actively seeking participants?
"Yes, the information on clinicaltrials.gov suggests that this research study is presently open to patients. The trial was first published on June 28th 2021 and has since been revised as of July 25th 2022. Approximately 48 participants are being sought from one site location."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger